14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.00 $75.66 Thursday, 25th Apr 2024 CYTK stock ended at $64.80. This is 3.02% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.22% from a day low at $64.00 to a day high of $65.42.
90 days $61.33 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Aug 20, 2020 $23.24 $24.29 $23.15 $24.21 1 049 705
Aug 19, 2020 $23.97 $24.17 $23.26 $23.33 461 173
Aug 18, 2020 $23.71 $24.15 $23.36 $24.12 542 715
Aug 17, 2020 $22.63 $23.94 $22.50 $23.36 1 188 899
Aug 14, 2020 $22.92 $22.92 $22.21 $22.52 553 264
Aug 13, 2020 $21.85 $22.88 $21.75 $22.85 490 253
Aug 12, 2020 $21.30 $21.96 $21.20 $21.92 804 793
Aug 11, 2020 $21.43 $22.09 $21.04 $21.08 866 274
Aug 10, 2020 $21.44 $21.87 $21.19 $21.33 655 379
Aug 07, 2020 $21.01 $22.00 $21.00 $21.51 1 172 631
Aug 06, 2020 $22.30 $22.72 $21.61 $21.64 400 875
Aug 05, 2020 $22.17 $22.51 $21.85 $22.13 1 308 842
Aug 04, 2020 $22.65 $22.67 $21.84 $22.02 805 991
Aug 03, 2020 $21.63 $22.83 $21.45 $22.66 568 382
Jul 31, 2020 $22.60 $22.66 $21.16 $21.62 1 229 026
Jul 30, 2020 $22.61 $23.32 $22.51 $22.67 696 988
Jul 29, 2020 $23.27 $23.55 $22.53 $22.96 720 549
Jul 28, 2020 $23.99 $24.13 $23.15 $23.18 759 274
Jul 27, 2020 $23.39 $24.39 $23.02 $24.10 612 053
Jul 24, 2020 $23.77 $24.01 $22.64 $23.08 880 643
Jul 23, 2020 $24.06 $25.21 $23.60 $24.23 833 060
Jul 22, 2020 $23.66 $24.27 $23.17 $23.88 626 400
Jul 21, 2020 $25.60 $25.60 $23.51 $23.87 997 300
Jul 20, 2020 $24.07 $25.72 $23.95 $25.14 3 325 000
Jul 17, 2020 $23.65 $24.00 $22.85 $23.98 4 889 400
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT